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Charles Bonnet syndrome in a
young  patient with a history of
epilepsy
Síndrome de  Charles  Bonnet en paciente
joven con  antecedentes de epilepsia
Dear  Editor:
Charles  Bonnet  syndrome  is  a rare  condition  which  usually
affects  elderly  patients,  especially  women,  due to  ophthal-
mological  involvement,  whether  due  to retinal  or  anterior
segment  disease.1,2 We  report  a case  of  Charles  Bonnet  syn-
drome  in  a  young  patient  with  bilateral  atrophy  of the optic
nerve  secondary  to  intracranial  hypertension  due  to cerebral
venous  thrombosis.
Our  patient  was  a 44-year-old  man  who  started  to  present
multiple  cerebral  venous  sinus  thrombosis  of unknown  ori-
gin  at  the  age  of  30.  Smoking  was  the only risk  factor  he
presented  at  the time  of  thrombosis.  Sequelae  of thrombo-
sis  were  partial  seizures  with  secondary  generalisation  and
sensory  symptoms  and  intracranial  hypertension  with  bilat-
eral  oedema  of  the  optical  nerve.  Treatment  was  started
with  acenocoumarol,  carbamazepine,  a  lumboperitoneal
shunt,  and  fenestration  of  both  optical  nerves,  which did
not  resolve  atrophy.  At  the  age  of  40,  as  partial  seizures
decreased  and 3  electroencephalography  studies  revealed
normal  results,  we  decided  to  suspend  antiepileptic
treatment.
At  the  age of  42,  he  developed  visual  hallucinations
of  serpentine  elements,  lasting  more  than  10  minutes;  we
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requested  a magnetic  resonance  imaging  (MRI)  study  to
rule  out  occipital  alterations,  due to  suspicion  of  sinus
rethrombosis.  No  changes  were  detected  with  regards  to
the previous  MRI studies.  We  requested  an additional  elec-
troencephalography;  results  were  considered  normal  for  the
patient’s  age.  Since  then,  the patient  has  reported  see-
ing a yellow  car  recurrently  appearing  at different  points
of  the visual  field,  in both  monocular  and  binocular  vision.
Episodes  lasted  from  seconds  to  hours, with  no  associated
symptoms,  disorientation,  or  headaches.  The  patient  did
not  associate  the visions  with  fatigue,  any  particular  activ-
ity,  or  with  changes  to  light conditions  or  position.  He
was  fully  aware of  the  phenomenon  and reported  that  hal-
lucinations  caused  him  no  discomfort;  therefore,  no new
treatment  was  started.  Visual  acuity  was  0.4  in  the right
eye  and  0.25  in the left.  He  presented  severe  atrophy  of
both  optic  nerves  (Fig.  1)  and  severely  restricted  visual  field
(Fig.  2).
Charles  Bonnet  syndrome  is  described  as  visual  hallu-
cinations  in patients  with  vision  loss.  The  syndrome  has
classically  been  described  in elderly patients,  especially
women.3 It consists  of a type of hallucinosis,  since  the
patient  is  fully  or  partially  aware  of the phenomenon,  which
usually  involves  a  high  level of  anxiety;  hallucinations  man-
ifest  suddenly,  with  no  voluntary  control.  Duration  ranges
from  seconds  to days.
Most  case  series  report  more  severe  visual  impairment
than  in  our  case,  with  the syndrome  manifesting  in  patients
with  macular  degeneration,  cataracts,  or  glaucoma.4 It  has
also  been  associated  with  such eye  treatments  as  photody-
namic  therapy,  laser  retinal  photocoagulation,  and  injection
of  anti-angiogenic  agents.  Before  establishing  a diagnosis,
and  given  the patient’s  history,  it  is  important  to  rule  out
such  other  causes  of  visual  hallucinations  as  inflammatory,
toxic-metabolic,  infectious,  and  especially  neurological  dis-
eases,  such  as  epilepsy,  migraine,  or  Lewy body  dementia.5
In this case,  there  was  high  suspicion  of epilepsy  due  to
occipital  lobe involvement,  given  the appearance  of  simple
hallucinosis;  with  more  complex  hallucinations,  it becomes
more  improbable.
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Figure  1  Optical  coherence  tomography  revealing  severe  atrophy  of  the  peripapillary  retinal  nerve  fibre  layers  of  both  optic
nerves.
Aetiopathogenesis  of  the syndrome  remains  unknown.
The  most  frequently  considered  theories  attribute  it to
deafferentiation;  according  to  this  hypothesis,  sensory  defi-
ciency  due  to  vision  loss  would cause  endogenous  activation
of  the  visual  cortex.2 No  model  is  completely  accepted,
and  none  explains  why  the  majority  of patients  with
impaired  vision  do not  present  hallucinations.  Therefore,
many authors  postulate  a possible  link between  the syn-
drome  and  the  presence  or  risk  of cognitive  impairment.6
However,  this  association  is  yet  to  be  demonstrated.
In  our  case,  despite  the  patient’s  good  visual acuity,
the  origin  of  hallucinations  may  be  related  with  a severely
impaired  visual  field  due  to  atrophy  of  the optical  nerve
secondary  to intracranial  hypertension.
As  previously  described,7 severely  impaired  visual
field  due  to  optic  tract  lesions  may  trigger  neuronal
deafferentiation  and  the development  of Charles  Bon-
net  syndrome  in patients  with  relatively  good visual
acuity.
In conclusion,  Charles  Bonnet  syndrome  is  a  complex
set  of  symptoms  of  increasing  incidence,  and  requires
a  multidisciplinary  approach  including  ophthalmologists,
neurologists,  and  psychiatrists  in  order  to  avoid  misdiagno-
sis  and  prescribe  correct  treatment.  Epilepsy  and  Charles
Bonnet  syndrome  may  coexist,  revealing  neuronal  network
dysfunction.8 Further  studies  are needed  to  achieve  greater
understanding  not  only  of  the  syndrome  but  also  of the  neu-
rophysiological  basis  of  hallucinations.
490  LETTERS  TO  THE  EDITOR
Figure  2  30-degree  Octopus  perimetry  results  showing  severely  restricted  visual  field  bilaterally.
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